Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Stay Study: PrEP for Transgender Persons
NCT03120936Phase 4Completed
- Sponsor
- Heluna Health
- Start
- Aug 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Heluna Health. Started Aug 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03120936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120936.